TEVA PHARMACEUTICAL-SP ADR (TEVA) Stock Institutional Trading Activity


TEVA PHARMACEUTICAL-SP ADR (TEVA) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q3 2025), investors with some of the largest reported share count changes include Viking Global Investors, Renaissance Technologies LLC, Sound Shore Management, Sequoia Financial Advisors, and ARK Invest. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2024Renaissance Technologies LLCBuy2,261,8007,697,163$108,607
Q1 2024Miller Value PartnersSell-1,80011,600$163,676
Q1 2024Sequoia Financial AdvisorsBuy411110,749$1,562,669
Q1 2024ARK InvestSell-30,670192,136$2,711,039
Q1 2024Sound Shore ManagementSell-1,424,5447,494,690$105,750,076
Q4 2023Renaissance Technologies LLCBuy1,417,4635,435,363$56,745
Q4 2023Miller Value PartnersSell-82513,400$139,896
Q4 2023Sequoia Financial AdvisorsBuy5,137110,338$1,151,929
Q4 2023Greenlight CapitalBuy268,470268,470$2,802,826
Q4 2023Abrams Capital ManagementSell-1,969,5975,996,836$62,606,968
Q4 2023ARK InvestSell-32,004222,806$2,326,095
Q4 2023Sound Shore ManagementBuy998,5228,919,234$93,116,803
Q3 2023Renaissance Technologies LLCSell-2,522,1604,017,900$40,983
Q3 2023Miller Value PartnersSell-67,91214,225$145,095
Q3 2023Sequoia Financial AdvisorsBuy827105,201$1,073,051
Q3 2023ARK InvestBuy16,887254,810$2,599,062
Q3 2023Sound Shore ManagementBuy7,920,7127,920,712$80,791,262
Q2 2023Renaissance Technologies LLCBuy5,4006,540,060$49,247
Q2 2023Miller Value PartnersSell-3,847,64782,137$618,492
Q2 2023Sequoia Financial AdvisorsSell-5,839104,374$785,937
Q2 2023ARK InvestBuy26,145237,923$1,791,560
Q1 2023Renaissance Technologies LLCBuy1,944,0976,534,660$57,832
Q1 2023Sequoia Financial AdvisorsBuy7,963110,213$975,386
Q1 2023Miller Value PartnersSell-1,217,2433,929,784$34,778,588
Q1 2023Abrams Capital ManagementSell-7,966,4327,966,433$70,502,932
Q1 2023ARK InvestSell-47,385211,778$1,874,235
Q4 2022Renaissance Technologies LLCBuy250,5634,590,563$41,866
Q4 2022Sequoia Financial AdvisorsBuy89,560102,250$932,520
Q4 2022Miller Value PartnersSell-4,107,8485,147,027$46,940,886
Q4 2022Abrams Capital ManagementSell-7,966,43115,932,865$145,307,729

Frequently asked questions about TEVA activity

  • Which institutional owners are buying TEVA?

    Institutional owners buying TEVA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in TEVA activity?

    "Buy" means an investor increased their reported position in TEVA compared to the prior reporting period. This reflects growing exposure to TEVA PHARMACEUTICAL-SP ADR (TEVA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in TEVA increasing?

    Institutional interest in TEVA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.